Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

1. Iranzo, V.
2. Sirera, R.
3. Carrato, A.
4. Cabrera, A.
5. Jantus, E.
6. Guijarro, R.
7. Sanmartín, E.
8. Blasco, A.
9. Gil, M.
10. Gómez-Aldaraví, L.
11. González-Larriba, J.L.
12. Massuti, B.
13. Velasco, A.
14. Provencio, M.
15. Rosell, R.
16. Camps, C.